MicroRNA Regulation of the Small Rho GTPase Regulators-Complexities and Opportunities in Targeting Cancer Metastasis

被引:21
作者
Humphries, Brock A. [1 ]
Wang, Zhishan [2 ]
Yang, Chengfeng [2 ]
机构
[1] Univ Michigan, Dept Radiol, Ctr Mol Imaging, 109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA
[2] Univ Kentucky, Dept Toxicol & Canc Biol, Coll Med, 1095 VA Dr, Lexington, KY 40536 USA
关键词
Rho GTPases; Rho GTPase regulators; RhoGEFs; RhoGAPs; RhoGDIs; microRNAs; cancer; metastasis; GUANINE-NUCLEOTIDE-EXCHANGE; GDP-DISSOCIATION INHIBITOR; CELL LUNG-CANCER; EPITHELIAL-MESENCHYMAL TRANSITION; ACTIVATING-PROTEIN INTERACTS; PREDICTS POOR-PROGNOSIS; POSITIVE FEEDBACK LOOP; TUMOR-SUPPRESSOR; BINDING-PROTEIN; BREAST-CANCER;
D O I
10.3390/cancers12051092
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The small Rho GTPases regulate important cellular processes that affect cancer metastasis, such as cell survival and proliferation, actin dynamics, adhesion, migration, invasion and transcriptional activation. The Rho GTPases function as molecular switches cycling between an active GTP-bound and inactive guanosine diphosphate (GDP)-bound conformation. It is known that Rho GTPase activities are mainly regulated by guanine nucleotide exchange factors (RhoGEFs), GTPase-activating proteins (RhoGAPs), GDP dissociation inhibitors (RhoGDIs) and guanine nucleotide exchange modifiers (GEMs). These Rho GTPase regulators are often dysregulated in cancer; however, the underlying mechanisms are not well understood. MicroRNAs (miRNAs), a large family of small non-coding RNAs that negatively regulate protein-coding gene expression, have been shown to play important roles in cancer metastasis. Recent studies showed that miRNAs are capable of directly targeting RhoGAPs, RhoGEFs, and RhoGDIs, and regulate the activities of Rho GTPases. This not only provides new evidence for the critical role of miRNA dysregulation in cancer metastasis, it also reveals novel mechanisms for Rho GTPase regulation. This review summarizes recent exciting findings showing that miRNAs play important roles in regulating Rho GTPase regulators (RhoGEFs, RhoGAPs, RhoGDIs), thus affecting Rho GTPase activities and cancer metastasis. The potential opportunities and challenges for targeting miRNAs and Rho GTPase regulators in treating cancer metastasis are also discussed. A comprehensive list of the currently validated miRNA-targeting of small Rho GTPase regulators is presented as a reference resource.
引用
收藏
页数:49
相关论文
共 460 条
[1]   Consensus transcriptome signature of perineural invasion in pancreatic carcinoma [J].
Abiatari, Ivane ;
DeOliveira, Tiago ;
Kerkadze, Vachtang ;
Schwager, Christian ;
Esposito, Irene ;
Giese, Nathalia A. ;
Huber, Peter ;
Bergman, Frank ;
Abdollahi, Amir ;
Friess, Helmut ;
Kleeff, Joerg .
MOLECULAR CANCER THERAPEUTICS, 2009, 8 (06) :1494-1504
[2]   Rho guanine nucleotide exchange factors involved in cyclic-stretch-induced reorientation of vascular endothelial cells [J].
Abiko, Hiyori ;
Fujiwara, Sachiko ;
Ohashi, Kazumasa ;
Hiatari, Ryuichi ;
Mashiko, Toshiya ;
Sakamoto, Naoya ;
Sato, Masaaki ;
Mizuno, Kensaku .
JOURNAL OF CELL SCIENCE, 2015, 128 (09) :1683-1695
[3]   Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis [J].
Adams, D. ;
Gonzalez-Duarte, A. ;
O'Riordan, W. D. ;
Yang, C. -C. ;
Ueda, M. ;
Kristen, A. V. ;
Tournev, I. ;
Schmidt, H. H. ;
Coelho, T. ;
Berk, J. L. ;
Lin, K. -P. ;
Vita, G. ;
Attarian, S. ;
Plante-Bordeneuve, V. ;
Mezei, M. M. ;
Campistol, J. M. ;
Buades, J. ;
Brannagan, T. H., III ;
Kim, B. J. ;
Oh, J. ;
Parman, Y. ;
Sekijima, Y. ;
Hawkins, P. N. ;
Solomon, S. D. ;
Polydefkis, M. ;
Dyck, P. J. ;
Gandhi, P. J. ;
Goyal, S. ;
Chen, J. ;
Strahs, A. L. ;
Nochur, S. V. ;
Sweetser, M. T. ;
Garg, P. P. ;
Vaishnaw, A. K. ;
Gollob, J. A. ;
Suhr, O. B. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (01) :11-21
[4]  
ADAMSON P, 1992, J BIOL CHEM, V267, P20033
[5]   IDENTIFICATION OF A NOVEL PROTEIN WITH GDP DISSOCIATION INHIBITOR ACTIVITY FOR THE RAS-LIKE PROTEINS CDC42HS AND RAC-I [J].
ADRA, CN ;
KO, J ;
LEONARD, D ;
WIRTH, LJ ;
CERIONE, RA ;
LIM, B .
GENES CHROMOSOMES & CANCER, 1993, 8 (04) :253-261
[6]   RhoGDI gamma: A GDP-dissociation inhibitor for Rho proteins with preferential expression in brain and pancreas [J].
Adra, CN ;
Manor, D ;
Ko, JL ;
Zhu, SC ;
Horiuchi, T ;
VanAelst, L ;
Cerione, RA ;
Lim, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (09) :4279-4284
[7]   miR-22 regulates expression of oncogenic neuro-epithelial transforming gene 1, NET1 [J].
Ahmad, Hafiz M. ;
Muiwo, Pamchui ;
Ramachandran, Suganthi S. ;
Pandey, Priyatama ;
Gupta, Yogendra K. ;
Kumar, Lalit ;
Kulshreshtha, Ritu ;
Bhattacharya, Alok .
FEBS JOURNAL, 2014, 281 (17) :3904-3919
[8]   Confirmation of the arginine-finger hypothesis for the GAP-stimulated GTP-hydrolysis reaction of Ras [J].
Ahmadian, MR ;
Stege, P ;
Scheffzek, K ;
Wittinghofer, A .
NATURE STRUCTURAL BIOLOGY, 1997, 4 (09) :686-689
[9]   ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression [J].
Ahn, Young-Ho ;
Gibbons, Don L. ;
Chakravarti, Deepavali ;
Creighton, Chad J. ;
Rizvi, Zain H. ;
Adams, Henry P. ;
Pertsemlidis, Alexander ;
Gregory, Philip A. ;
Wright, Josephine A. ;
Goodall, Gregory J. ;
Flores, Elsa R. ;
Kurie, Jonathan M. .
JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (09) :3170-3183
[10]   Activation of RhoA and SAPK/JNK signalling pathways by the RhoA-specific exchange factor mNET1 [J].
Alberts, AS ;
Treisman, R .
EMBO JOURNAL, 1998, 17 (14) :4075-4085